Advances in the diagnosis and treatment of viral hepatitis B and C in China

• Published in: Chinese medical journal Vol. 135; no. 4; pp. 379 - 380
• Main Author: Jia, Jidong
• Format: Journal Article
• Language: English
• Published: China Lippincott Williams & Wilkins 20.02.2022; Lippincott Williams & Wilkins Ovid Technologies; Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China; Wolters Kluwer
• Subjects: Antiretroviral drugs; Antiviral drugs; China; Disease prevention; DNA, Viral; Hepatitis B; Hepatitis B - diagnosis; Hepatitis B - drug therapy; Hepatitis B virus; Hepatitis C; Hepatitis, Viral, Human - diagnosis; Hepatology; Humans; Immunization; Infections; Infectious diseases; Liver; Medical diagnosis; Medical treatment; Public health; China; Beijing China

[16] The proportion of entecavir (ETV) and tenofovir disoproxil fumarate (TDF) in the prescribed antiviral agents had increased from 13.5% in 2003 to 79.7% in 2016 as shown by an analysis of the China Registry of Hepatitis B.[18] In 2019, the price of generic ETV and TDF has reduced by 90%, and the...